Search research articles
Contact Us
Filters
Showing results (121-130 of 227) with videos related to
Page
of 23
Sort By:
The Journal of General Virology
|
September 10, 2010
No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication
Ivonne Nieuwenhuis, Niels Beenhakker, Willy M J M Bogers, et al.
Journal of Virology
|
November 23, 2000
Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity
D Glykofrydes, H Niphuis, E M Kuhn, et al.
Rejuvenation Research
|
March 24, 2007
Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination
Richard Aspinall, Jeffrey Pido-Lopez, Nesrina Imami, et al.
The Journal of General Virology
|
August 11, 2004
Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope
Sally A Sharpe, Alethea Cope, Stuart Dowall, et al.
Vaccine
|
January 27, 2004
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120
David Davis, Helen Donners, Betty Willems, et al.
Virology
|
March 11, 2006
Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection
Rong Xu, Indresh K Srivastava, Larene Kuller, et al.
Journal of Virology
|
June 14, 2000
Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection
K Mori, Y Yasutomi, S Sawada, et al.
Journal of Medical Primatology
|
February 1, 1992
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines
J L Heeney, P de Vries, R Dubbes, et al.
The Journal of General Virology
|
July 23, 2004
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen
B Mäkitalo, P Lundholm, J Hinkula, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 1998
Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques
Y Wang, L Tao, E Mitchell, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 227) with videos related to
Sort By:
Page
of 23
The Journal of General Virology
|
September 10, 2010
No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication
Ivonne Nieuwenhuis, Niels Beenhakker, Willy M J M Bogers, et al.
Journal of Virology
|
November 23, 2000
Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity
D Glykofrydes, H Niphuis, E M Kuhn, et al.
Rejuvenation Research
|
March 24, 2007
Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination
Richard Aspinall, Jeffrey Pido-Lopez, Nesrina Imami, et al.
The Journal of General Virology
|
August 11, 2004
Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope
Sally A Sharpe, Alethea Cope, Stuart Dowall, et al.
Vaccine
|
January 27, 2004
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120
David Davis, Helen Donners, Betty Willems, et al.
Virology
|
March 11, 2006
Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection
Rong Xu, Indresh K Srivastava, Larene Kuller, et al.
Journal of Virology
|
June 14, 2000
Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection
K Mori, Y Yasutomi, S Sawada, et al.
Journal of Medical Primatology
|
February 1, 1992
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines
J L Heeney, P de Vries, R Dubbes, et al.
The Journal of General Virology
|
July 23, 2004
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen
B Mäkitalo, P Lundholm, J Hinkula, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 1998
Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques
Y Wang, L Tao, E Mitchell, et al.
Page
of 23